Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.

Wiernik, Andres; Foley, Bree; Zhang, Bin; Verneris, Michael R; Warlick, Erica; Gleason, Michelle K; Ross, Julie A; Luo, Xianghua; Weisdorf, Daniel J; Walcheck, Bruce; Vallera, Daniel A; Miller, Jeffrey S.
Clin Cancer Res; 19(14): 3844-55, 2013 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-23690482